Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
Mon Compte
No element in selection

Favoris
Établissements de santé
Contact Abonnez-vous aux actualités

0 result

Topics : Quality of care and patient safety
Topics : Patient safety
Topics : Esthetics
Topics : Ethics
Active substance : biotine
Active substance : chlore actif
Active substance : fructose
Active substance : huile de ricin
Active substance : hyaluronidase
Active substance : thiocolchicoside
Active substance : zinc

Topic

Economics and public health (1)
Plus ...
- Ethics (1)
Diagnostic and therapeutic techniques (1)
Plus ...
- Esthetics (1)
Quality of care and patient safety (1)
Plus ...

Drugs, devices and medical acts (1)
Plus ...
- Health technology assessment (1)

inconnu (1)
industriels (1)

Français (1)

Active substance

acide ascorbique (1)
alcool (1)
aminophylline (1)
artichaut (1)
azathioprine (1)
biotine (1)
calcitonine de saumon (1)
chlore actif (1)
colchicine (1)
fructose (1)
huile de ricin (1)
hyaluronidase (1)
hydrocortisone (1)
iode (1)
mannitol (1)
minoxidil (1)
pentoxifylline (1)
phosphate (1)
piroxicam (1)
prednisolone (1)
pyridoxine (1)
riboflavine (1)
sodium (1)
thiocolchicoside (1)
zinc (1)

More filter Other Filter Icon

Other Filter Icon

Search Export

Follow us :

Advancing quality in the fields of health and social care services

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

4dn6PNk79Q33qc7s